DIPHTHERIA, TETANUS, PERTUSSIS, HEPATITIS B, Hib VACCINE

On this page

Prevention of tetanus, diphtheria, pertussis, hepatitis B and severe Haemophilus influenzae type B infections in children from 6 weeks to 7 years of age (primary vaccination)

Pentavalent vaccine combining tetanus toxoid, diphtheria toxoid, whole-cell pertussis toxoid, recombinant adsorbed hepatitis B vaccine and Haemophilus influenzae type B polysaccharide
Suspension for injection in multidose vial, for IM injection into the anterolateral part of the thigh in children < 2 years and into the deltoid muscle in children ≥ 2 years.
DO NOT ADMINISTER INTO THE GLUTEAL MUSCLE.

Neonate: 3 doses 4 weeks apart, preferably before the age of 6 months. It is recommended to administer the 1^st dose at 6 weeks of age, the 2^nd dose at 10 weeks of age and the 3^rd dose at 14 weeks of age.
If a child has not received the 1^st dose by the age of 1 year, start vaccination as soon as possible according to the 0-1-6 schedule: 2 doses 4 weeks apart, then a 3^rd dose 6 months after the 1^st dose

Do not administer in the event of allergic reactions to a previous dose of vaccine containing these strains.
Do not administer at birth to vaccinate against hepatitis B.
Vaccination should be postponed in the event of severe acute febrile illness; minor infections are not contra-indications.
May cause: mild local reactions (redness, pain at the injection site), fever, pain, malaise, headache, myalgia; rarely: anaphylactic reactions.
If administered simultaneously with other vaccines, use different syringes and injection sites.

Also comes in:
- a trivalent vaccine (diphtheria, tetanus, pertussis) and tetravalent vaccine (diphtheria, tetanus, pertussis, hepatitis B) used for primary vaccination in children < 7 years;
- a bivalent Td vaccine containing a reduced dose of diphtheria toxoid (tetanus-diphtheria), used in children ≥ 4 years, adolescents and adults.

– Between 2 °C and 8 °C. Do not freeze.